Manufacturer record
Aristo Pharmaceuticals Pvt. Ltd. Plot Nos.: 2040-46: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Aristo Pharmaceuticals Pvt. Ltd. Plot Nos.: 2040-46 (Sikkim) were declared Not of Standard Quality between November 2025 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Aristo Pharmaceuticals Pvt. Ltd. Plot Nos.: 2040-46 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Pantoprazole Gastro-resistant Tablets IP 40 mg | SPK251470Mfg 2025-10 · Exp 2028-03 | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab | Jul 2026 |
| Pantoprazole Sodium Gastro-resistant and Domperidone Prolonged -release Capsules IP | SPA250021Mfg 2025-01 · Exp 2026-12 | The sample does not conform to claim as per IP 2022 in respect to the Test of Identification by HPLC and Assay of Pantoprazole Sodium calculated as Pantoprazole, Domperidone.Assay | RDTL,ChandigarhCDSCO lab | Nov 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.